The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
Weighing the Benefits of Combination Therapy in Crohn's Disease
March 10th 2014Recent studies suggest that combination therapy with infliximab and azathioprine is more effective than monotherapy in patients with newly diagnosed Crohn's disease, but patients with more established Crohn's disease do not derive any extra benefit from triple therapy with infliximab, methotrexate, and prednisone compared to double therapy with infliximab and prednisone.
Opioid-Induced Constipation Is Not Adequately Reported by Chronic Non-Cancer Pain Patients
Preliminary research data revealed a significantly higher incidence of opioid-induced constipation among patients taking opioid analgesics for chronic non-cancer pain than self-reported constipation complaints suggest.
Expanded Cancer Guidelines Now Include Lynch Syndrome Screening
At the beginning of Colon Cancer Awareness month, the National Comprehensive Cancer Network expanded its guidelines to include Lynch syndrome screening, which should dramatically increase the number of patients eligible for hereditary colon cancer testing.
Preventing the Spread of Vaccine-Preventable Disease Among Diabetic Patients
February 26th 2014While the dangers of influenza and pneumococcal pneumonia in patient with diabetes are well understood, less known is the fact that diabetics are at increased risk for contracting hepatitis B if they share blood glucose meters, finger stick devices, or other diabetes-care equipment.
FDA Updates Warning Label for Hepatitis C Antiviral Drug
February 19th 2014The Food and Drug Administration has updated a drug warning label and medication guide for Victrelis (boceprevir) after receiving reports of abnormally low levels of red and white blood cells in patients who received it as part of combination treatment for hepatitis C.